Veracyte, Inc.
VCYT
$24.32
$0.682.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.51% | 2.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.51% | 2.39% | |||
| Cost of Revenue | -12.64% | 9.24% | |||
| Gross Profit | 0.65% | -0.44% | |||
| SG&A Expenses | 4.53% | 5.08% | |||
| Depreciation & Amortization | -11.14% | -4.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.93% | 6.87% | |||
| Operating Income | 2.50% | -35.63% | |||
| Income Before Tax | 115.74% | -79.56% | |||
| Income Tax Expenses | 122.81% | -198.64% | |||
| Earnings from Continuing Operations | 37.83% | -66.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.83% | -66.26% | |||
| EBIT | 2.50% | -35.63% | |||
| EBITDA | -4.93% | -21.97% | |||
| EPS Basic | 37.03% | -66.51% | |||
| Normalized Basic EPS | 75.44% | -58.47% | |||
| EPS Diluted | 46.82% | -67.74% | |||
| Normalized Diluted EPS | 76.30% | -58.95% | |||
| Average Basic Shares Outstanding | 0.54% | 0.77% | |||
| Average Diluted Shares Outstanding | 0.19% | 1.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||